SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Actuate Therapeutics CEO Reports $49,999.62 Share Acquisition

President, CEO and Director Daniel M. Schmitt reported acquiring $49,999.62 in common shares.

ACTU

Related stories